Injective
INJ - # 162 ActiveGobal AssetPlunge # 46
-
Rating Score 74.60Rating Grade B+
- Rating Version APYWA-v1.1 / Rating Date 2025-12-22
Overview
Injective (INJ) is a blockchain platform designed to support decentralized exchanges (DEXs) and derivatives trading, providing an efficient environment for trading financial products. Injective offers high transaction speeds and low fees, aiming to decentralize financial services. The INJ token is used for paying transaction fees, participating in governance, and activating the ecosystem.
Metric Radar Chart
Metric Bar Chart
Metric Trends
| Total Rating Score | TNNeutral |
|---|---|
| Market Accessibility | TNNeutral |
| Development Activity | TNNeutral |
| Market Liquidity | TH2Gradual Uptrend |
| Community Engagement | TNNeutral |
| Risk & Security | TNNeutral |
Total Rating Score Trend
Market Data
- Token Price $4.582765 (↘4.30%)
- Volume (24h) $28.23M (↘53.60%)
- Market Cap $458.14M (↗2.33%)
-
Circulating Supply
99,970,935 INJ
100,000,000 INJ
(Source : Coinmarketcap , Coingecko )
Listed Exchanges
- Korean
-
- Global
-
×
View All Exchanges
- Korean
-
- Global
-
Community Info
X (Twitter) Tweets (Last 30 Days)
- (-)
Development Info
-
GitHub Account
InjectiveLabs
-
Stars
835 (-)
- Commits (Last 3 Months) 4.93K (-246)
Security Audit Info
- Security Audit Status CertiK
- CertiK Code Security Score 93 pts
(Source : Coinmarketcap , CertiK Skynet )
Issue Info
- Trading History
- 2025.02.05 가상자산 로고가 변경되었습니다.
- 2022.11.01 가상자산 명칭이 [ (기존) 인젝티브프로토콜(Injective Protocol) → (변경) 인젝티브(Injective) ]로 변경되었습니다.
- Risk History
- No records found
View Full History
| Category | Date | Exchange | Link | Grade | Details |
|---|---|---|---|---|---|
| Regular Evaluation | 2025-04-21 | - | - | B+(72.92) | [AW-0049-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-04-17 | - | - | B+(72.74) | [AW-0048-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-04-14 | - | - | B+(72.80) | [AW-0047-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-04-10 | - | - | B+(73.34) | [AW-0046-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-04-07 | - | - | B+(72.62) | [AW-0045-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-04-03 | - | - | B+(72.92) | [AW-0044-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-03-31 | - | - | B+(72.80) | [AW-0043-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-03-27 | - | - | B+(73.52) | [AW-0042-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-03-24 | - | - | B+(73.10) | [AW-0041-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-03-20 | - | - | B+(73.52) | [AW-0040-정기] 평가가 완료되었습니다. |
- Disclaimer
-
The ratings provided by APYWA (hereinafter 'the Company') are conducted via an automated system based on public data and are pure data-driven analysis results with no subjective elements. This rating material includes evaluations on five key metrics: Market Accessibility, Development Activity, Market Liquidity, Community Engagement, and Security. All information provided is for reference purposes only.
Our ratings are not intended as investment advice or recommendations, and we do not guarantee the accuracy, completeness, or timeliness of the information. Users must make their own investment decisions based on the provided data, and the Company bears no legal liability for any resulting losses or damages.
While the rating material is processed automatically based on reliable data, discrepancies with actual market conditions may occur due to data limitations. Therefore, the Company is not liable for any damages arising from the use of the provided information. All information contained herein is the property of the Company and may not be reproduced, distributed, or modified without prior approval.